MHC Class II-restricted antigen presentation by plasmacytoid dendritic cells drives proatherogenic T cell immunity
about
The role of T and B cells in human atherosclerosis and atherothrombosisAntigen-Presenting Cells and Antigen Presentation in Tertiary Lymphoid OrgansBatf3-dependent CD8α+ Dendritic Cells Aggravates Atherosclerosis via Th1 Cell Induction and Enhanced CCL5 Expression in Plaque Macrophages.MAb therapy against the IFN-α/β receptor subunit 1 stimulates arteriogenesis in a murine hindlimb ischaemia model without enhancing atherosclerotic burden.Evaluation of the BDCA2-DTR Transgenic Mouse Model in Chronic and Acute Inflammation.Beyond vascular inflammation--recent advances in understanding atherosclerosis.Linking CD11b (+) Dendritic Cells and Natural Killer T Cells to Plaque Inflammation in Atherosclerosis.The multifaceted biology of plasmacytoid dendritic cells.Plasmacytoid dendritic cells orchestrate TLR7-mediated innate and adaptive immunity for the initiation of autoimmune inflammation.IDO-orchestrated crosstalk between pDCs and Tregs inhibits autoimmunity.Commentary: Indoleamine 2,3-Dioxygenase-Expressing Aortic Plasmacytoid Dendritic Cells Protect against Atherosclerosis by Induction of Regulatory T Cells.Targeting the adaptive immune system: new strategies in the treatment of atherosclerosis.Readapting the adaptive immune response - therapeutic strategies for atherosclerosis.Targeting inflammation to reduce cardiovascular disease risk: a realistic clinical prospect?Immune-mediated mechanisms of atherosclerosis and implications for the clinic.Dendritic cell migration in health and disease.Perivascular adipose tissue inflammation in vascular disease.Regulatory Dendritic Cells.Perivascular mast cells regulate vein graft neointimal formation and remodeling.The cathelicidin protein CRAMP is a potential atherosclerosis self-antigen in ApoE(-/-) mice.S1PR4 Signaling Attenuates ILT 7 Internalization To Limit IFN-α Production by Human Plasmacytoid Dendritic Cells.
P2860
Q27000791-AC6AF9ED-B411-43C3-92E2-47E49303230BQ28079346-60951160-D320-4575-AC83-65F2C20BAD82Q30847000-A084C94C-7613-4C9C-AF2A-C47BBE74320DQ35620995-B76D3FE3-4B79-4DC8-822C-3B1C6B920D8FQ35740053-DB92E989-A03A-41A4-A65F-899FA6A34B5AQ36079808-E5B1F88D-A892-4AEF-9D39-48D670AEEF74Q36718932-F7C7BF94-6112-41F7-944E-8FCEB8DB3799Q36731249-8B14320C-5205-46C9-9A68-8F25A6AD643DQ36796084-4C09FF57-280F-4A76-A426-0471DD4EFFF5Q37452783-E66F9CD1-6C16-490E-BEE7-F28D972681D3Q37638628-ECE9CFE5-5189-432B-98F0-47346E82660DQ38406177-548B41DC-F45A-4D1C-8D8E-71C40D061F66Q38774904-7557C936-C6E1-4123-AFA2-B09C92FA7C74Q38836998-21D6871C-E1A7-491D-BD2E-CE4AD1CFFD0EQ38851472-9AAFDE2A-DFAD-41C1-AC07-52F3C4FC61EDQ39021691-E9AAC470-8DA1-4BCA-BEA7-408AEE873C24Q39072710-BF2F00DC-9F80-4A1D-918F-368622671714Q40049981-ACAE4432-14B3-4213-9E51-CA8C88424DC5Q40602634-9CA4AE53-D6C5-4C37-887C-BA1B92C309FBQ46485465-8667D38D-B96F-453B-8103-8CADB71DB800Q48259591-FC9F21B2-644B-47EF-8EB2-045062DAB152
P2860
MHC Class II-restricted antigen presentation by plasmacytoid dendritic cells drives proatherogenic T cell immunity
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
MHC Class II-restricted antige ...... proatherogenic T cell immunity
@ast
MHC Class II-restricted antige ...... proatherogenic T cell immunity
@en
type
label
MHC Class II-restricted antige ...... proatherogenic T cell immunity
@ast
MHC Class II-restricted antige ...... proatherogenic T cell immunity
@en
prefLabel
MHC Class II-restricted antige ...... proatherogenic T cell immunity
@ast
MHC Class II-restricted antige ...... proatherogenic T cell immunity
@en
P2093
P2860
P50
P1433
P1476
MHC Class II-restricted antige ...... proatherogenic T cell immunity
@en
P2093
Alison J Finigan
Deirdre Murphy
Göran K Hansson
Hafid Ait-Oufella
Helen Cambrook
James E Harrison
Lauren L Baker
Leanne M Masters
Pasquale Maffia
Stéphanie Hugues
P2860
P304
P356
10.1161/CIRCULATIONAHA.114.011090
P407
P577
2014-09-15T00:00:00Z